Biostax Corp.
BTAX
$0.01
$0.00111.11%
06/30/2024 | 03/31/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 13.45% | -5.11% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 13.08% | -9.55% | |||
Operating Income | -13.08% | 9.55% | |||
Income Before Tax | -26.97% | 68.00% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -26.97% | 68.00% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -26.97% | 68.00% | |||
EBIT | -13.08% | 9.55% | |||
EBITDA | -13.78% | 9.94% | |||
EPS Basic | -27.50% | 68.25% | |||
Normalized Basic EPS | -28.00% | 10.71% | |||
EPS Diluted | -150.00% | 68.25% | |||
Normalized Diluted EPS | -28.00% | 10.71% | |||
Average Basic Shares Outstanding | -0.02% | 0.07% | |||
Average Diluted Shares Outstanding | -2.43% | 2.54% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |